Atlas Trials

Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease

Clinical trial NCT04541407 · COMPLETED

Trial details

NCT number
NCT04541407
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non Small Cell Lung CancerCNS Progression
Start date
2020-10-29
Primary completion
2022-04-25
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.